Which treatment for patent foramen ovale in cryptogenic stroke?

Area of Science:

• Neurology
• Cardiology
• Vascular Medicine

Background:

• Cryptogenic stroke, a stroke of unknown origin, frequently co-occurs with patent foramen ovale (PFO).
• Patent foramen ovale is an atrial septal defect that can allow paradoxical embolism, leading to stroke.
• The optimal management strategy for patients with cryptogenic stroke and PFO remains debated.

Purpose of the Study:

• To review the factors influencing the management of cryptogenic stroke in patients with PFO.
• To present a practical algorithm for decision-making in these complex cases.
• To highlight the lack of established consensus and the need for individualized treatment plans.

Main Methods:

• Review of current literature on cryptogenic stroke and PFO.
• Analysis of patient-specific factors, including stroke etiology and PFO morphology.
• Consideration of contraindications to antithrombotic therapy and patient preferences.
• Development of a proposed management algorithm.

Main Results:

• Management decisions are multifactorial, integrating stroke risk, PFO features, patient comorbidities, and treatment tolerability.
• The proposed algorithm provides a structured approach to guide clinical decision-making.
• Individualized patient assessment is crucial due to the absence of a universal management consensus.

Conclusions:

• The management of cryptogenic stroke with PFO requires a comprehensive evaluation of multiple clinical parameters.
• The presented algorithm offers a reasonable framework for clinicians managing these patients.
• Further research and consensus development are needed to refine treatment strategies for PFO-associated cryptogenic stroke.